Pharmaceutical Commerce

NOVEMBER 19, 2023

CareMetx, a Hub services company that provides high-touch support to drive therapy initiation and adherence, conducted research involving over 100 participants, using both qualitative and quantitative methods. The primary aim was to understand how therapy manufacturers envision the future of Hubs.

40

40

Pharmaceutical Technology

APRIL 25, 2023

Global healthcare company AmerisourceBergen has launched a cell and gene therapy (CGT) integration hub. Through the CGT integration hub, our goal is to increase connectivity and reduce potential barriers across the patient journey, simplifying the care coordination process and enabling an enhanced patient and provider experience.”

52

52

IDStewardship

FEBRUARY 25, 2024

The incorporation of effective laboratory processes supports the systematic application of best practices needed to be good stewards of antibiotics. Easy-to-understand communication of the science around #AMR is super important, and I think @CDCgov coming out with a dedicated resource hub is pretty fantastic.” – Amanda Suchanek, Ph.D.

Communication 208

Communication Patient Care Hospitals 208

European Pharmaceutical Review

MARCH 21, 2024

million strategic initiative is set to support UK advanced therapy medicinal product (ATMP) clinical trials, and help the region maintain its position as a leader in clinical research. An additional four years of funding for the Advanced Therapy Treatment Centre ( ATTC ) network is available through this programme.

93

93

European Pharmaceutical Review

MAY 23, 2023

Several of these were biotech companies self-commercialising their innovative therapies without large pharma support and choosing Switzerland as their European hub.

110

110

Pharmaceutical Technology

DECEMBER 5, 2022

With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub. With an initial focus on enchaining mRNA technology and developing a vaccine for Chlamydia, the research at the hub is anticipated to commence in the first quarter of next year.

Vaccines 98

Vaccines Communication Immunization 98

Pharmaceutical Commerce

NOVEMBER 19, 2023

Among a variety of Hub vendors, what specific qualities distinguish differentiated support for drug manufacturers? To help answer this question, CareMetx conducted in-depth interviews and surveys with senior leadership at top manufacturers.

40

40

pharmaphorum

MARCH 7, 2022

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. . The global training hub.

Vaccines 98

Vaccines 98

European Pharmaceutical Review

FEBRUARY 19, 2024

The programme aims to support the limited capacity within the industry in LMICs. The Biomanufacturing Workforce Training Initiative will be upheld by three pillars: Existing capacity building activities within the Organisation Global Training Hub for Biomanufacturing (GTH-B) Regional training centres.

Vaccines 74

Vaccines 74

European Pharmaceutical Review

APRIL 28, 2023

Each hub has specific and complementary multidisciplinary research expertise. Each National Hub will receive individual funding, with awards linking directly to those of the other three countries. These elements form the consortium’s core values alongside knowledge mobilisation, output sharing and mutual cross-regional learning.

90

90

Hospital Pharmacy Europe

OCTOBER 26, 2023

In a suite of 10 recommendations, it also highlighted the need for guidance on making the best use of skill mix and called for tools such as a competency development framework to support the development of ‘a range of progressive roles for pharmacists’, including within preventive healthcare and prescribing.

Documentation 52

Documentation Hospitals 52

Pharma Times

FEBRUARY 22, 2021

Services will be offered to staff who have been affected by the COVID-19 pandemic

43

43

European Pharmaceutical Review

NOVEMBER 23, 2023

UK partnership set to revolutionise oligonucleotide manufacture Supporting demand for oligonucleotide medicines Current capacity for manufacturing oligonucleotides “is insufficient” CPI stated. It will utilise £20 million to support construction & kit-out the facility, CPI stated on X.

Packaging 83

Packaging 83

pharmaphorum

JULY 29, 2021

Krishnanjan Alaparthi explores how tech-driven hub services can help manage the complexities of specialty pharma. Specialty pharmacies now have to be ready to not only meet patient demand, but also provide patients the support they need to secure reimbursement, properly administer the drug, and ensure adherence and optimal outcomes.

Specialty Pharmacies 111

Specialty Pharmacies FDA 111

STAT

SEPTEMBER 8, 2023

… Novartis is changing the name — and the guiding strategy — of its research and development hub in Cambridge, Mass. Very smooth. Here’s some news for your Friday morning. “We want that alignment.”

108

108

European Pharmaceutical Review

DECEMBER 22, 2022

Steve Barclay, Health and Social Care Secretary added: “By boosting our onshore vaccine manufacturing capability, we are a step closer to becoming the leading global hub for life sciences. Moderna has also committed to invest in UK-based R&D activities over the next decade.

Vaccines 128

Vaccines 128

pharmaphorum

DECEMBER 13, 2022

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences hub in Canary Wharf moved to the next stage. Earnshaw building. The building will be a “vertical campus” with 823,000 sq. million sq.

59

59

European Pharmaceutical Review

MARCH 14, 2024

Following the facility expansion, L HOUSE will “firmly establish itself as a global vaccine hub… We will make every effort to achieve successful development and supply of a vaccine with blockbuster potential,” Jaeyong Ahn, CEO of SK bioscience shared. billion by 2028, based on data from Evaluate Pharma.

Vaccines 83

Vaccines 83

Pharmaceutical Technology

SEPTEMBER 26, 2022

Nature of Disruption: When used in conjunction with Nordic's current products, the nRF7002 offers Wi-Fi 6 connectivity and Wi-Fi-based location using service set identifier (SSID) detection of local hubs. Key smart home features can operate whether or not accessories can connect to the internet and irrespective of a dedicated hub or bridge.

Packaging 52

Packaging 52

Pharmaceutical Technology

APRIL 10, 2023

It shows the potential of Northern Ireland to become an internationally renowned life and health science hub, aligning with Belfast Region City Deal investments in data science and clinical trial provision and the All-Island Cancer Research Institute.”

Immunization 103

Immunization 103

European Pharmaceutical Review

DECEMBER 21, 2022

The agreement focuses on collaboration in four key areas including localising innovative industries, R&D , innovation and sustainability at a global scale to enhance the United Arab Emirates (UAE’s) position as a global hub for future industries.

84

84

Roots Analysis

FEBRUARY 26, 2024

Types of Molecules and Regions Worldwide Overall, the growth is anticipated to be spread across multiple type of molecules and different geographical regions.

52

52

The FDA Law Blog

JANUARY 11, 2024

Boasting a highly skilled workforce, state-of-the-art facilities, and a supportive business environment, it’s no surprise that Puerto Rico has become a hub for industry pioneers in biopharma, research, supply chain management and technology. HPM is a co-sponsor of the event. The event is hosted by by Porzio, Bromberg & Newman.

Controlled Substances 59

Controlled Substances 59

Pharma Mirror

APRIL 24, 2022

NorthX has recently established an innovation hub to offer support to partners in achieving their long-term drug development goals. The company’s ability to handle new ways of working and experience with unique development demands was crucial in Abera’s decision-making.

Vaccines 52

Vaccines 52

European Pharmaceutical Review

JUNE 27, 2022

The money will go towards the installation of new drug substance production equipment and warehousing facilities to support ambient and cold storage at two sites: College Park in Blanchardstown and Monksland Industrial Park in Athlone.

78

78

European Pharmaceutical Review

JULY 6, 2023

Developing the innovative cancer immunotherapies To help deliver this development of these cancer immunotherapies, BioNTech plans to set up a regional hub in England and new laboratories, expected to have a capacity for over 70 scientists in Cambridge.

Vaccines 89

Vaccines 89

Pharma Marketing Network

DECEMBER 29, 2020

Meet Our Guest Panelists: Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Commercial Model Innovation. SAVE MY SEAT. Ryan Billings , Head, US Oncology Digital Marketing & Customer Experience at GSK. SAVE MY SEAT.

Communication 98

Communication 98

European Pharmaceutical Review

JULY 13, 2022

This collaboration allows us to exchange scientific expertise to further this mission and support Afrigen’s globally important research and vaccine discovery efforts,” commented Dr Richard Koup, Acting Director of the NIAID Vaccine Research Center (VRC).

Vaccines 72

Vaccines 72

NICE

MAY 30, 2023

This is equal to the delivery of up to 24,000 virtual ward beds and £450m additional funding over two years has been made available to systems to support this transformation. NICE will develop case studies and implementation support tools highlighting benefits and barriers. Expected publication October 2023.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

JUNE 24, 2022

This investment in Global Health R&D will support the company’s efforts for bringing next-generation vaccines and therapies for malaria and tuberculosis, offering shorter therapy options for patients. These hubs have over 30 potential vaccines and treatments that act on 13 high-burden infectious diseases. falciparum malaria.

Vaccines 59

Vaccines 59

European Pharmaceutical Review

SEPTEMBER 12, 2022

In doing so, we are supporting our broader ambition to enable faster development and focused prioritisation across our global portfolio.”. Johann campus in Basel with the creation of a $100 million biologics hub to complement the existing Novartis Institutes for BioMedical Research (NIBR) Biologics Center.

Compounding 106

Compounding 106

PharmaShots

JUNE 12, 2023

The nearly 69,000-square-foot facility is Avantor’s most recent investment in expanding its global footprint to both meet customer needs and support the future growth of both Avantor and our customers. Many biomanufacturers choose Ireland as a commercial manufacturing hub due to its established infrastructure. Sheri Lewis: Yes.

49

49

pharmaphorum

JANUARY 10, 2023

We aim to strengthen the “tech” in BioNTech with our agreement to acquire @instadeepai to support our strategy to build world leading capabilities in #AI – and #ML -driven #drugdiscovery and development of next-generation immunotherapies and vaccines. link] pic.twitter.com/XHh0Y009fK. Karim Beguir – InstaDeep.

Immunization 116

Immunization Vaccines 116

Hospital Pharmacy Europe

JULY 27, 2023

Progress on Government commitments to support both hospital and community pharmacy services in England ‘require improvement’, an expert panel commissioned by the parliamentary Health and Social Care Committee has found. He added: ‘Outdated paper prescribing is still the norm in too many settings.

Community Pharmacies 92

Community Pharmacies Hospitals Patient Care 92

pharmaphorum

JULY 7, 2021

ABPI chief executive Richard Torbett said it is an “ambitious…blueprint for how the UK can become a global hub for life sciences and, in turn, a science superpower.” billion) in financing between March and end-May, ranking third after the US hubs in Massachusetts and San Francisco. billion ($2.2

Documentation 59

Documentation Vaccines 59

Pharmaceutical Technology

JANUARY 11, 2023

BioNTech stated that the deal supports its strategy to build capabilities in AI-driven drug discovery and immunotherapies and vaccine development. The acquisition will help the company enhance its research collaborators network globally and expand its footprint in hubs across the US, Africa, Europe, and the Middle East.

Vaccines 69

Vaccines 69

pharmaphorum

DECEMBER 22, 2022

.” He added: “As this deal shows, with the right support and backing from government, our industry can drive forward innovation-led growth, and deliver the high quality, high value jobs our economy needs.”

Vaccines 122

Vaccines 122